BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 29536319)

  • 1. Association between physician characteristics and the use of 21-gene recurrence score genomic testing among Medicare beneficiaries with early-stage breast cancer, 2008-2011.
    Wilson LE; Pollack CE; Greiner MA; Dinan MA
    Breast Cancer Res Treat; 2018 Jul; 170(2):361-371. PubMed ID: 29536319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surgeon and medical oncologist peer network effects on the uptake of the 21-gene breast cancer recurrence score assay.
    Zipkin R; Schaefer A; Chamberlin M; Onega T; O'Malley AJ; Moen EL
    Cancer Med; 2021 Feb; 10(4):1253-1263. PubMed ID: 33455068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncologists' influence on receipt of adjuvant chemotherapy: does it matter whom you see for treatment of curable breast cancer?
    Katz SJ; Hawley ST; Bondarenko I; Jagsi R; Ward KC; Hofer TP; Kurian AW
    Breast Cancer Res Treat; 2017 Oct; 165(3):751-756. PubMed ID: 28689364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Second Opinions From Medical Oncologists for Early-Stage Breast Cancer: Prevalence, Correlates, and Consequences.
    Kurian AW; Friese CR; Bondarenko I; Jagsi R; Li Y; Hamilton AS; Ward KC; Katz SJ
    JAMA Oncol; 2017 Mar; 3(3):391-397. PubMed ID: 28033448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patterns of multidisciplinary care in the management of non-metastatic invasive breast cancer in the United States Medicare patient.
    Churilla TM; Egleston BL; Murphy CT; Sigurdson ER; Hayes SB; Goldstein LJ; Bleicher RJ
    Breast Cancer Res Treat; 2016 Nov; 160(1):153-162. PubMed ID: 27640196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regional-Level Correlations in Inappropriate Imaging Rates for Prostate and Breast Cancers: Potential Implications for the Choosing Wisely Campaign.
    Makarov DV; Soulos PR; Gold HT; Yu JB; Sen S; Ross JS; Gross CP
    JAMA Oncol; 2015 May; 1(2):185-94. PubMed ID: 26181021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variation in the Types of Providers Participating in Breast Cancer Follow-Up Care: A SEER-Medicare Analysis.
    Neuman HB; Schumacher JR; Schneider DF; Winslow ER; Busch RA; Tucholka JL; Smith MA; Greenberg CC
    Ann Surg Oncol; 2017 Mar; 24(3):683-691. PubMed ID: 27709403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of Gene Expression Profiling and Chemotherapy in Early-Stage Breast Cancer: A Study of Linked Electronic Medical Records, Cancer Registry Data, and Genomic Data Across Two Health Care Systems.
    Afghahi A; Mathur M; Thompson CA; Mitani A; Rigdon J; Desai M; Yu PP; de Bruin MA; Seto T; Olson C; Kenkare P; Gomez SL; Das AK; Luft HS; Sledge GW; Sing AP; Kurian AW
    J Oncol Pract; 2016 Jun; 12(6):e697-709. PubMed ID: 27221993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of organizational affiliations and research networks in the diffusion of breast cancer treatment innovation.
    Carpenter WR; Reeder-Hayes K; Bainbridge J; Meyer AM; Amos KD; Weiner BJ; Godley PA
    Med Care; 2011 Feb; 49(2):172-9. PubMed ID: 21206296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gynecologic oncologist impact on adjuvant chemotherapy care for stage II-IV ovarian cancer patients.
    Weeks KS; Lynch CF; West M; Carnahan R; O'Rorke M; Oleson J; McDonald M; Stewart SL; ; Charlton M
    Gynecol Oncol; 2022 Jan; 164(1):3-11. PubMed ID: 34776243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physician-level variation in axillary surgery in older adults with T1N0 hormone receptor-positive breast cancer: A retrospective population-based cohort study.
    Minami CA; Jin G; Freedman RA; Schonberg MA; King TA; Mittendorf EA
    J Geriatr Oncol; 2024 Jun; 15(5):101795. PubMed ID: 38759256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surgeon influence on use of needle biopsy in patients with breast cancer: a national medicare study.
    Eberth JM; Xu Y; Smith GL; Shen Y; Jiang J; Buchholz TA; Hunt KK; Black DM; Giordano SH; Whitman GJ; Yang W; Shen C; Elting L; Smith BD
    J Clin Oncol; 2014 Jul; 32(21):2206-16. PubMed ID: 24912900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Collaboration Between Surgeons and Medical Oncologists and Outcomes for Patients With Stage III Colon Cancer.
    Hussain T; Chang HY; Veenstra CM; Pollack CE
    J Oncol Pract; 2015 May; 11(3):e388-97. PubMed ID: 25873063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of US Oncologist Rurality by Practice Setting and Patients Served.
    Cornelius SL; Shaefer AP; Wong SL; Moen EL
    JAMA Netw Open; 2024 Jan; 7(1):e2350504. PubMed ID: 38180759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use and Costs of Disease Monitoring in Women With Metastatic Breast Cancer.
    Accordino MK; Wright JD; Vasan S; Neugut AI; Hillyer GC; Hu JC; Hershman DL
    J Clin Oncol; 2016 Aug; 34(24):2820-6. PubMed ID: 27161970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physician variation in lung cancer treatment at the end of life.
    Green JB; Shapiro MF; Ettner SL; Malin J; Ang A; Wong MD
    Am J Manag Care; 2017 Apr; 23(4):216-223. PubMed ID: 28554208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of doctor-patient communication on patients' perceptions of their risk of breast cancer recurrence.
    Janz NK; Li Y; Zikmund-Fisher BJ; Jagsi R; Kurian AW; An LC; McLeod MC; Lee KL; Katz SJ; Hawley ST
    Breast Cancer Res Treat; 2017 Feb; 161(3):525-535. PubMed ID: 27943007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterizing patient-oncologist communication in genomic tumor testing: The 21-gene recurrence score as an exemplar.
    O'Neill SC; Vadaparampil ST; Street RL; Moore TF; Isaacs C; Han HS; Augusto B; Garcia J; Lopez K; Brilleman M; Jayasekera J; Eggly S
    Patient Educ Couns; 2021 Feb; 104(2):250-256. PubMed ID: 32900604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors Associated With Oncologist Discussions of the Costs of Genomic Testing and Related Treatments.
    Yabroff KR; Zhao J; de Moor JS; Sineshaw HM; Freedman AN; Zheng Z; Han X; Rai A; Klabunde CN
    J Natl Cancer Inst; 2020 May; 112(5):498-506. PubMed ID: 31675070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Association Between Oncology Outreach and Timely Treatment for Rural Patients with Breast Cancer: A Claims-Based Approach.
    Scodari BT; Schaefer AP; Kapadia NS; Brooks GA; O'Malley AJ; Moen EL
    Ann Surg Oncol; 2024 Jul; 31(7):4349-4360. PubMed ID: 38538822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.